Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Prader-Willi Syndrome Forecast in 9 Major Markets Report 2016-2026 - Analysis, Technologies & Forecasts - Research and Markets

Research and Markets
Posted on: 13 Sep 16

Research and Markets has announced the addition of the "Prader-Willi Syndrome Forecast in 9 Major Markets 2016-2026" report to their offering.

This report provides the current prevalent population for Prader-Willi disease across 9 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil, Japan and India) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Several of the main symptoms and co-morbidities of Prader-Willi disease have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Prader-Willi disease include:

  • Cardiovascular Problems
  • Obstructive sleep apnoea and respiratory disorders
  • Diabetes Type II
  • Autism Spectrum Disorder Behavioural Characteristics
  • Seizures
  • Hip dysplasia
  • Scoliosis

Reason to Buy:

  • Able to quantify patient populations in global Prader-Willi disease's market to target the development of future products, pricing strategies and launch plans.
  • Gain further insight into the prevalence of the subdivided types of Prader-Willi disease and identify patient segments with high potential.
  • Identify sub-populations within Prader-Willi disease which require treatment.
  • Gain an understanding of the specific markets that have the largest number Prader-Willi disease patients.

Report Structure:

1. Introduction

2. Cause of the Disease

3. Risk Factors & Prevention

4. Diagnosis of the Disease

5. Variation by Geography/Ethnicity

6. Disease Prognosis & Clinical Course

7. Key Co-morbid Conditions/ Features Associated with the Disease

8. Methodology for Quantification of Patient Numbers

9. Top-Line Prevalence for Prader-Willi Syndrome

10. Main Complications and Features of Prader-Willi Patients

11. Abbreviations used in the Report

12. Patient-Based Offering

13. Online Pricing Data and Platforms

14. References

15. Appendix

For more information about this report visit http://www.researchandmarkets.com/research/t4f9d3/praderwilli

Related Topics: Pharmaceuticals

View source version on businesswire.com: http://www.businesswire.com/news/home/20160913006365/en/

Business Wire
www.businesswire.com

Last updated on: 13/09/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.